Donna Elizabeth Moore, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2528 Wheaton Way #206, Bremerton, WA 98310 Phone: 360-373-8272 Fax: 360-373-7054 |
Jay Michael Van Bockel, PTA Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2701 Clare Ave, Bremerton, WA 98310 Phone: 360-377-3951 Fax: 360-377-5443 |
Dr. Daniel J Soetaert, DO Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 742 Lebo Blvd Ste A, Bremerton, WA 98310 Phone: 360-744-4950 Fax: 253-572-1071 |
Stephan Paul Bellande, Physical Medicine & Rehabilitation - Sports Medicine Medicare: Not Enrolled in Medicare Practice Location: 1292 Ne Mount Olympus Ln Apt B303, Bremerton, WA 98311 Phone: 360-701-1851 |
News Archive
Numerate, Inc. and Intellikine, Inc. today announced the successful conclusion of their research collaboration to discover novel small molecule compounds targeting the PI3K/mTOR signaling pathway. The collaboration combined Intellikine's unique capabilities in x-ray crystal structure-guided medicinal chemistry and drug discovery with Numerate's powerful computational drug design platform to identify potent, selective and drug-like inhibitors of PI3 kinase alpha, an important target in cancer therapy.
In patients with high blood pressure resistant to treatment who also have obstructive sleep apnea (OSA), the more severe their OSA, the higher their blood pressure, according to new research published online in the Annals of the American Thoracic Society.
Phylogeny, the in situ company, and Neoprobe, a diversified developer of innovative biomedical surgical oncology products, announce their collaboration to develop head and neck cancer detection technology.
The presence of the protein poly (ADP-ribose) polymerase (PARP) in tumours can help predict their response to chemotherapy, a German scientist will tell the seventh European Breast Cancer Conference (EBCC7) in Barcelona tomorrow (Saturday 27 March). Professor Gunter von Minckwitz, from the German Breast Group Forschungs GmBH, Neu-Isenburg, says that, contrary to current belief that PARP is associated with a limited number of tumours, he and his team found for the first time that PARP expression exists across all breast cancer subtypes, and that such tumours were highly sensitive to chemotherapy.
Over the last decade, as activists started pushing colleges to accommodate transgender students, they first raised only basic issues, like recognizing a name change or deciding who could use which bathrooms.
› Verified 4 days ago